𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Measurement of patient outcome in arthritis

✍ Scribed by Dr. James F. Fries; Patricia Spitz; R. Guy Kraines; Halsted R. Holman


Publisher
John Wiley and Sons
Year
1980
Tongue
English
Weight
726 KB
Volume
23
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Collaboration with patients in the desig
✍ Joanna Nicklin; Fiona Cramp; John Kirwan; Marie Urban; Sarah Hewlett πŸ“‚ Article πŸ“… 2010 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 112 KB πŸ‘ 3 views

## Abstract ## Objective Patient‐reported outcome measures (PROMs) need to include concepts and language relevant to patients and be easily understood. These studies aimed to develop draft PROMs to measure rheumatoid arthritis (RA) fatigue and its impact by collaborating with patients to identify

Computerized measurement of magnetic res
✍ Paul Bird; Marissa Lassere; Ron Shnier; John Edmonds πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 208 KB πŸ‘ 3 views

## Abstract ## Objective One of the major aims of therapy in rheumatoid arthritis (RA) is to prevent erosive disease and subsequent disability. One of the important goals of therapy assessment must therefore be the accurate measurement of damage progression. We undertook this study to assess the f

Toward an Understanding of Patient Outco
✍ James F. Fries πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 English βš– 753 KB

It is difficult to objectively measure the effects of arthritis or its treatment, and agreement on satisfactory endpoints has not been reached. Each proposed measure, from ring size to 50-foot walking time to articular index, has had its several proponents and its many critics. Now, new questionnair

Patient perspective of measuring treatme
✍ T. Sanderson; M. Morris; M. Calnan; P. Richards; S. Hewlett πŸ“‚ Article πŸ“… 2010 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 140 KB πŸ‘ 1 views

## Abstract ## Objective Collaboration with patients with rheumatoid arthritis (RA) highlights that outcomes important to them include fatigue, coping, and life enjoyment. However, these are not commonly measured in clinical trials. There is little evidence about which outcomes patients would prio